HOME › Conferences

Conferences

Logo	Description
	World EPA Congress World EPA Congress Europe 2026 is the world's largest and most crucial gathering dedicated to pharmaceutical market access, pricing strategies, and generating robust evidence. It serves as a vital platform for limitless networking, bringing together over 1,500 attendees from pharma, biotech, and key Payers/HTAs (Health Technology Assessment bodies). The event is structured across 10 tracks, focusing on critical industry challenges, including evolving reimbursement models, the complexities of accessing treatments for Rare Diseases, the strategic implications of the EU Joint Clinical Assessment (JCA), and leveraging Real-World Evidence (RWE) and AI to define the value and access of innovative medicines across Europe.
	World Vaccine Congress Washington The World Vaccine Congress Washington 2026 is the largest and most established global meeting dedicated to the entire vaccine value chain, spanning from fundamental research to commercial manufacturing and equitable global access. Scheduled for March 30 – April 2, 2026, at the Walter E. Washington Convention Center, this vital event unites over 4,000 attendees from science, government, and industry. It aims to drive groundbreaking progress and essential partnering in the sector. Key focus areas include Pandemic Platforms, Cancer & Immunotherapy, Emerging Infectious Diseases, Clinical Trials, and Bioprocessing, fostering discussions crucial for the future development and delivery of vaccines worldwide.
	World Orphan Drug Congress USA The World Orphan Drug Congress is the largest global event dedicated to rare diseases and orphan drug innovation, bringing together more than 2,000 attendees, 280 speakers, and 100 exhibitors. It unites industry leaders, scientists, regulators, and patient advocates to explore breakthroughs in cell and gene therapies, clinical development for small populations, regulatory strategies, global market access, and real-world evidence. The event offers deep insights into improving diagnostics, advancing cutting-edge treatments, and expanding equitable access for patients worldwide. With expert sessions, hands-on workshops, and extensive networking, it is a premier forum for driving progress across the full rare disease value chain.
	World Vaccine Congress Europe The World Vaccine Congress Europe will bring together more than 2,000 attendees, 280 speakers and over 150 exhibitors and start-ups for a comprehensive exploration of the vaccine ecosystem. The event features presentations from leading global organizations including WHO, PATH, GSK, Moderna and CEPI, alongside panel debates addressing key scientific and policy challenges. Attendees can benefit from extensive networking through dedicated breaks and receptions, connect with solution providers in a broad exhibition area, and engage in a dynamic start-up zone designed to link innovators with investors seeking promising early-stage vaccine technologies and fostering collaboration across the global vaccine community for progress.
	World Orphan Drug Congress Europe The World Orphan Drug Congress Europe is the leading global event dedicated to orphan drugs and rare diseases. Bringing together more than 1,800 participants, it offers insights from over 250 industry experts and showcases 130+ exhibitors. The congress unites professionals across the full orphan drug lifecycle, covering regulatory policy, global market access, advanced gene therapies, and more. Attendees include senior leaders in R&D, gene therapy, personalised medicine, rare disease research, patient advocacy, ATMP associations, investment, regulatory affairs, and government, creating an unparalleled platform for collaboration, innovation, and strategic discussion in the rare disease and orphan drug community.